E-LIB Suche - Ergebnisse für: Olmez, Omer Fatih

1

Real-World Efficacy and Safety of First-Line Nivolumab Plus..:

Kutlu, Yasin ; Dae, Shute Ailia ; Yilmaz, Feride...
Cancers. 16 (2024) 12 - p. 2251 , 2024

Link: https://doi.org/10.3390/..

2

Beyond traditional therapies: clinical significance of comp..:

Olmez, Omer Fatih ; Bilici, Ahmet ; Er, Ozlem...
Japanese Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1093/..

3

Prognostic significance of HER2 loss after HER2-targeted ne..:

Kutlu, Yasin ; Cekin, Ruhper ; Aydin, Sabin Goktas...
Current Problems in Cancer. 50 (2024) - p. 101102 , 2024

Link: https://doi.org/10.1016/..

4

Objective Response Rate is a Surrogate Marker for Long-Term..:

Tural, Deniz ; Arslan, Cagatay ; Selcukbiricik, Fatih...
Clinical Genitourinary Cancer. 22 (2024) 5 - p. 102163 , 2024

Link: https://doi.org/10.1016/..

5

Major and minor salivary gland cancers: A multicenter retro..:

Hacioglu, Muhammet Bekir ; Erdogan, Bulent ; Bardakcı, Murat...
Head & Neck. 45 (2023) 7 - p. 1643-1653 , 2023

Link: https://doi.org/10.1002/..

6

The Prognostic Role of Mismatch Repair Status and CDX-2 Exp..:

Aydin, Sabin Goktas ; Olmez, Omer Fatih ; Selvi, Oguzhan...
Journal of Gastrointestinal Cancer. 55 (2023) 1 - p. 227-236 , 2023

Link: https://doi.org/10.1007/..

7

Is there any prognostic significance in pleural involvement..:

Güner, Gürkan ; Aktaş, Burak Yasin ; Başal, Fatma Buğdaycı...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 14 - p. 13271-13277 , 2023

Link: https://doi.org/10.1007/..

8

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte r..:

Kutlu, Yasin ; Aydin, Sabin Goktas ; Bilici, Ahmet...
Medicine. 102 (2023) 15 - p. e33432 , 2023

Link: https://doi.org/10.1097/..

9

Predictive significance of inflammatory markers and mGPS in..:

Goktas Aydin, Sabin ; Kutlu, Yasin ; Muglu, Harun...
Cancer Chemotherapy and Pharmacology. 93 (2023) 1 - p. 71-78 , 2023

Link: https://doi.org/10.1007/..

10

The modified Glasgow prognostic score (MGPS) and the mortal..:

Tunay, Burcu ; Olmez, Omer Fatih ; Bilici, Ahmet...
Journal of Surgery and Medicine. 7 (2023) 1 - p. 6-10 , 2023

Link: https://doi.org/10.28982..

11

Five-Year Outcome and Safety in Patients Treated With Immun..:

Tural, Deniz ; Arslan, Cagatay ; Selcukbiricik, Fatih...
Clinical Genitourinary Cancer. 21 (2023) 3 - p. 334-341 , 2023

Link: https://doi.org/10.1016/..

12

Prognostic factors for regorafenib treatment in patients wi..:

Goktas Aydin, Sabin ; Kavak, Engin Eren ; Topcu, Atakan...
Biomolecules and Biomedicine. , 2023

Link: https://doi.org/10.17305..

13

The SOCS-1 -1478CA/del functional polymorphism (rs33989964)..:

Hartavi, Mustafa ; Olmez, Omer Fatih ; Oral, Barbaros..
Molecular Biology Reports. 50 (2023) 4 - p. 3489-3492 , 2023

Link: https://doi.org/10.1007/..

14

Atezolizumab combined with chemotherapy in the first-line t..:

Gürbüz, Mustafa ; Kutlu, Yasin ; Akkuş, Erman...
Journal of Cancer Research and Clinical Oncology. 148 (2022) 12 - p. 3547-3555 , 2022

Link: https://doi.org/10.1007/..

15

Atezolizumab in Patients with Metastatic Urothelial Carcino..:

Tural, Deniz ; Ölmez, Ömer Fatih ; Sümbül, Ahmet Taner...
European Urology Focus. 7 (2021) 5 - p. 1061-1066 , 2021

Link: https://doi.org/10.1016/..